Less Alzheimer's pathology with angiotensin receptor blocker use

(HealthDay)—In autopsy findings, patients treated with angiotensin receptor blockers (ARBs) show less Alzheimer's disease (AD)-related pathology, according to a study published online Sept. 10 in the Archives of Neurology.

Read more at: http://medicalxpress.com/news/2012-09-alzheimer-pathology-angiotensin-receptor-blocker.html#jCp